Acceleron Pharma Inc.
ACTRIIB ANTAGONISTS AND DOSING AND USES THEREOF
Last updated:
Abstract:
In certain aspects, the present invention provides compositions and methods for promoting bone growth and increasing bone density, as well as for the treatment of multiple myeloma. Methods for dosing a patient with an ActRIIb antagonist are also provided.
Status:
Application
Type:
Utility
Filling date:
27 May 2020
Issue date:
22 Apr 2021